Session Details
[29-10-pm]Social Pharmacy 2, Regulatory sciences
Sun. Mar 29, 2026 1:10 PM - 3:10 PM JST
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Room 10 (C303, Bldg. 2, Area 2 [3F])
Chair: Kota Kodama, Shuji Shimada
[29-10-pm01]Enhancing Medication Literacy Through a National Telepharmacy Call Center in Israel: Consultation Overview and High Patient Satisfaction
○Eyal Schwartzberg1,2, Ran Nissan2, Maria Hurgin2, Hen Popilski2, Khaleel Zahalka2, Rana Cohen2, Merav Ben Natan3 (1. School of Pharmacy, Ben Gurion University of the Negev, Israel, 2. Pharmaceutical Society of Israel, 3. Pat Matthews Academic School of Nursing, Hillel Yaffe Medical, Center, Israel)
[29-10-pm02S]Non-adherence to instillation intervals and orders and its risk factors in glaucoma patients using multiple topical medications
○Toma Hamasaki1, Shingo Kondo1,2, Hiroki Iwata1,2, Noriko Kobayashi1,2, Yuko Okamoto1,2, Katsunori Yamaura1,2 (1. Div. Social Pharm, Keio Univ., 2. Keio Univ Commun Pharm)
[29-10-pm03]Pharmacists’ Role in Addressing Medication Waste and the Impact of Medical DX on Improving Work Efficiency
○Mizutani Reiko1 (1. Faculty of Pharmaceutical Sciences, Hokkaido University of Science)
[29-10-pm04]Social Effectiveness of Pharmacist Interventions in Community Pharmacy
○Takenori Tamaki1, Yuji Yoshiyama2 (1. KUSURINOMIDORI Co., Ltd. MIDORI Pharmacy, 2. Kitasato University School of Pharmacy)
[29-10-pm05S]Impact of Multiregional Clinical Trials on the Frequency of Revision of Package Inserts for New Efficacy Drugs in Japan and the United States
○Takaki Moriyama1, Kosuke Koyama1, Sho Kodama1, Koichi Masuyama1, Kunihiko Kitagaki1 (1. Tokyo University of Pharmacy and Life Science)
[29-10-pm06S]Consideration on Information Extraction from Review Reports of Medicines by ChatGPT
○Miyu Ikai1, Miyu Tanaka1, Hideki Maeda1 (1. Meiji Pharmaceutical Univ.)
[29-10-pm07S]Implementation of a Mathematical Model Incorporating Vaccine Side Effects for Benefit-Risk Assessment of Human Papillomavirus Vaccines
○Sae Ito1, Gabriela Ester Tanaka2, Katura Tsukamoto1 (1. Gifu Pharm. Univ., 2. SUNDRUG)
[29-10-pm08]Quantitative Assessment of Inpatient Hypnotic Use and Fall Risk:
Utilizing DDDs/1000bed-days for Regional Collaboration
○Minako Yoshihara1, Miho Okamoto1, Kayoko Takahashi1, Kengo Tabata1 (1. Dept. Pharm., Kanto Central Hosp.)
[29-10-pm09]Descriptive analysis of information regarding anti-drug antibodies in Japanese package insert
○Kodai Yajima1, Hikaru Sato1, Sho Masui1, Hiroko Shibata2, Kazuko Nishimura2, Akiko Ishii-Watabe2, Atsushi Yonezawa1 (1. Keio University, 2. Natl. Inst. Health Sci.)
[29-10-pm10S]Outpatient standard-dose-equivalent persons during COVID-19:a time-series study using NDB date
○Yoshito Okawa1, Marie Suehiro1, Takahiro Muro1 (1. Pharm.Sci.,Nagasaki International Univ.)
